ResearcherShandong Tumor HospitalActive in the last 2 years

Ziyuan Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0001-6696-3374; OpenAlex author ID A5102461539. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Machine-Learning-Driven Discovery of N-Phenylbenzenesulfonamides as a Novel Chemotype for Lactate Dehydrogenase A Inhibition with Anti-Pancreatic Cancer Activi… Co-author DOI 10.1021/acs.jmedchem.5c00359 ↗
[18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00259-023-06271-8 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaojin Zhang · 1 shared paper, 2025 · strength 0.22
- Paper Machine-Learning-Driven Discovery of N-Phenylbenzenesulfonamides as a Novel Chemotype for Lactate Dehydrogenase A Inhib… DOI 10.1021/acs.jmedchem.5c00359 ↗
Qijie Gong · 1 shared paper, 2025 · strength 0.22
- Paper Machine-Learning-Driven Discovery of N-Phenylbenzenesulfonamides as a Novel Chemotype for Lactate Dehydrogenase A Inhib… DOI 10.1021/acs.jmedchem.5c00359 ↗
Jinbo Yue · 1 shared paper, 2023 · strength 0.18
- Paper [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoper… DOI 10.1007/s00259-023-06271-8 ↗
Xiang Zhang · 1 shared paper, 2023 · strength 0.18
- Paper [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoper… DOI 10.1007/s00259-023-06271-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.